उत्पाद विवरण
Azacytin 100 mg Injection is an essential anticancer therapy designed to manage myelodysplastic syndrome (MDS), a condition characterized by the production of defective blood cells by the bone marrow, which can result in a deficiency of healthy blood components. This innovative medication falls under the category of demethylation agents, functioning by inhibiting the process of DNA methylation that often leads to irregular gene activity and cellular malfunctions. By targeting and disrupting this process, Azacytin helps restore normal gene function, thereby fostering the generation of healthy blood cells while simultaneously eliminating abnormal ones in the bone marrow. Patients receiving Azacytin should be aware of potential side effects and the importance of regular blood monitoring, as treatment can influence blood cell counts. This medication is typically administered under the supervision of a healthcare professional to ensure optimal outcomes and patient safety. If you're seeking a solution for MDS, Azacytin 100 mg Injection may offer a pathway to improve your blood health and overall well-being. Always consult with your healthcare provider to discuss the benefits and risks associated with this treatment.
Send Email 
जांच भेजें
जांच भेजें
एसएमएस भेजें
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese